Biogen and its rivals

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Biogen and its rivals

Postby Needled » Fri Mar 27, 2009 5:36 am

This article describes a Phase III trial of a new formulation of Avonex taken every two or four weeks and comments on competition with Tysabri and some of the oral meds in trial. Looks like Cladribine and Fingolimod are still on track for FDA filing this year. Novartis releases its first quarter results on April 23, so there should be an update on Fingolimod then as well.

http://www.thestreet.com/story/10477612 ... ivals.html
User avatar
Needled
Family Elder
 
Posts: 361
Joined: Wed Jan 14, 2009 4:00 pm
Location: Connecticut

Advertisement

Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users